Prediction Markets Eye IonQ Micron Anduril as Potential Next US Government Stake Targets After Quantum Investments US Jobless Claims Drop to Lowest Level Since MidMay Signaling Robust Labor Market Top AI Infrastructure Stocks for 2026 Sector Analysis and Market Outlook NASA Selects Blue Origin for Key Moon Base Mission Edging Out SpaceX Treasury Yield Spread Narrows to OneYear Low as Traders Bet on Higher Rates Under New Fed Chair Warsh Aluminum Price Surge Amid Iran Conflict Pressures Major US Companies Spectral AI Inc MDAI Q1 2026 Earnings Missed Estimates as EPS Falls Short Shares Decline PACCAR Q1 2026 Earnings EPS Slightly Misses Estimates Stock Holds Steady DEI Q1 2026 Earnings EPS Surprise of 604 Highlights Operational Discipline SVV Q1 2026 Earnings Missed EPS by a Narrow Margin Shares Edge Higher CDLX Q1 2026 Earnings NarrowerThanExpected Loss Signals Operating Discipline Datadog Q1 2026 Earnings EPS Surges Past Estimates as Strong Profitability Drives Stock Higher Chart Industries GTLS Holds Steady Near Support Amid Industrial Sector Shifts Antero Resources AR Slips 106 as Natural Gas Sector Faces Headwinds Sleep Number Stock Hovers Near Support as Traders Eye Key Levels Dragonfly Energy Holdings DFLI Gains 16 as Stock Holds Above Key Support Level Auddia Inc AUUD Slides 688 as Sellers Test Key Support Near 142 SpaceX OpenAI Anthropic FirstDay Valuations Could Surpass Berkshire Hathaway Polymarket Traders Suggest ACRE Q1 2026 Earnings Disappointing EPS Miss Amidst Challenging Commercial Real Estate Market MediaAlpha MAX Edges Higher in Quiet Trading Holds Near Key Support GALT Q1 2026 Earnings WiderThanExpected Loss as ClinicalStage Biotech Continues RD Spend CIMN Q1 2026 Earnings EPS Beats Estimates Amid Steady Performance ABCB Q1 2026 Earnings Ameris Bancorp Beats EPS Estimates with 257 Surprise VINP Q1 2026 Earnings Earnings Miss Pressures Shares Amid Disappointing Quarter GLAD Q1 2026 Earnings EPS Misses Estimates Shares Rise Despite 2057 Surprise MCRB Q1 2026 Earnings EPS Misses Estimates Stock Declines 417 SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development